Lysozyme Amyloid for Synthetic RNA Delivery.

Benjamin Beluzo, Maytham Ismail, Sergei Chuikov, Venkateshwar G Keshamouni, Mathumai Kanapathipillai

Abstract read

In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Benjamin BeluzoDepartment of Mechanical Engineering, University of Michigan-Dearborn, Dearborn, MI 48128, USA.ORCID 0009-0005-4104-6368

Maytham IsmailDepartment of Mechanical Engineering, University of Michigan-Dearborn, Dearborn, MI 48128, USA.ORCID 0000-0001-7625-9076

Sergei ChuikovDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

Venkateshwar G KeshamouniDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

Mathumai KanapathipillaiDepartment of Mechanical Engineering, University of Michigan-Dearborn, Dearborn, MI 48128, USA.ORCID 0000-0001-8748-6848

Funding

Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary FibrosisR01HL156998 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KESHAMOUNI, VENKATESHWAR G, KIM, KEVIN KEEWOUN · 2022 to 2025

$2.4M

CSRD VA I01 CX002233NHLBI NIH HHS R01 HL156998NIH HHS 1R01HL156998-01A1NIH HHS 1R15GM135766United States Department of Veterans Affairs CX002233-01A2U.S. National Science Foundation 1919560

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amyloid aggregateslysozymeRNA delivery

Identifiers

PMID41012432

DOI10.3390/pharmaceutics17091094

PMCPMC12473952

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.